Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 40 Records) |
| Query Trace: Neoplasms and HSD3B1[original query] |
|---|
| Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects. Cancer causes & control : CCC 2015 Jan 26 (1): 121-31. Nyante Sarah J, Gammon Marilie D, Kaufman Jay S, Bensen Jeannette T, Lin Dan Yu, Barnholtz-Sloan Jill S, Hu Yijuan, He Qianchuan, Luo Jingchun, Millikan Robert |
| Interactions between dietary acrylamide intake and genes for ovarian cancer risk. European journal of epidemiology 2017 Apr . Hogervorst Janneke G F, van den Brandt Piet A, Godschalk Roger W L, van Schooten Frederik-Jan, Schouten Leo |
| HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer. Nature reviews. Urology 2017 12 15 (3): 191-196. Hettel Daniel, Sharifi Ni |
| HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer. JAMA oncology 2017 10 4 (4): 554-557. Almassi Nima, Reichard Chad, Li Jianbo, Russell Carly, Perry Jaselle, Ryan Charles J, Friedlander Terence, Sharifi Ni |
| Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer. JAMA oncology 2017 Oct . Hearn Jason W D, Xie Wanling, Nakabayashi Mari, Almassi Nima, Reichard Chad A, Pomerantz Mark, Kantoff Philip W, Sharifi Ni |
| HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer. The Journal of clinical investigation 2018 6 128 (8): 3333-3340. Alyamani Mohammad, Emamekhoo Hamid, Park Sunho, Taylor Jennifer, Almassi Nima, Upadhyay Sunil, Tyler Allison, Berk Michael P, Hu Bo, Hwang Tae Hyun, Figg William Douglas, Peer Cody J, Chien Caly, Koshkin Vadim S, Mendiratta Prateek, Grivas Petros, Rini Brian, Garcia Jorge, Auchus Richard J, Sharifi Ni |
| Germline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate Cancer. Clinical genitourinary cancer 2018 4 16 (4): 288-292. Hahn Andrew W, Gill David M, Nussenzveig Roberto H, Poole Austin, Farnham Jim, Cannon-Albright Lisa, Agarwal Neer |
| Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer. Clinical genitourinary cancer 2019 7 17 (5): 389-394. Stangl-Kremser Judith, Lemberger Ursula, Hassler Melanie R, Bruchbacher Andreas, Ilijazi Dafina, Garstka Nathalie, Kramer Gero, Haitel Andrea, Abufaraj Mohammad, Shariat Shahrokh |
| Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone. JAMA network open 2019 Feb 2 (2): e190115. Shiota Masaki, Narita Shintaro, Akamatsu Shusuke, Fujimoto Naohiro, Sumiyoshi Takayuki, Fujiwara Maki, Uchiumi Takeshi, Habuchi Tomonori, Ogawa Osamu, Eto Masatos |
| Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer. Prostate cancer and prostatic diseases 2019 11 23 (2): 316-323. Chen William S, Feng Eric L, Aggarwal Rahul, Foye Adam, Beer Tomasz M, Alumkal Joshi J, Gleave Martin, Chi Kim N, Reiter Robert E, Rettig Matthew B, Evans Christopher P, Small Eric J, Sharifi Nima, Zhao Shuang |
| Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT. Cancer biology & therapy 2020 Aug 1-3. Handy Whitney F, Schmidt Keith T, Price Douglas K, Figg William |
| HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies. Annals of oncology : official journal of the European Society for Medical Oncology 2020 6 31 (9): 1186-1197. Khalaf D J, Aragón I M, Annala M, Lozano R, Taavitsainen S, Lorente D, Finch D L, Romero-Laorden N, Vergidis J, Cendón Y, Oja C, Pacheco M I, Zulfiqar M, , Gleave M E, Wyatt A W, Olmos D, Chi K N, Castro |
| Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype. Annals of oncology : official journal of the European Society for Medical Oncology 2020 5 31 (9): 1178-1185. Lu C, Terbuch A, Dolling D, Yu J, Wang H, Chen Y, Fountain J, Bertan C, Sharp A, Carreira S, Isaacs W B, Antonarakis E S, De Bono J S, Luo |
| HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer. JAMA oncology 2020 2 6 (4): e196496. Hearn Jason W D, Sweeney Christopher J, Almassi Nima, Reichard Chad A, Reddy Chandana A, Li Hong, Hobbs Brian, Jarrard David F, Chen Yu-Hui, Dreicer Robert, Garcia Jorge A, Carducci Michael A, DiPaola Robert S, Sharifi Ni |
| Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer. JCI insight 2021 Sep . Kruse Megan L, Patel Mona, McManus Jeffrey, Chung Yoon-Mi, Li Xiuxiu, Wei Wei, Bazeley Peter S, Nakamura Fumihiko, Hardaway Aimalie, Downs Erinn, Chandarlapaty Sarat, Thomas Mathew, Moore Halle Cf, Budd George T, Tang W H Wilson, Hazen Stanley L, Bernstein Aaron, Nik-Zainal Serena, Abraham Jame, Sharifi Ni |
| Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: a systematic overview. American journal of cancer research 2021 6 11 (5): 1873-1894. Liu Min, Shi Hongzhe, Yan Jiaqing, Zhang Yuan, Ma Yinglin, Le Kaidi, Li Zhongdong, Xing Nianzeng, Li Guoh |
| Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study. Cancers 2021 4 13 (8): . Prizment Anna E, McSweeney Sean, Pankratz Nathan, Joshu Corinne E, Hwang Justin H, Platz Elizabeth A, Ryan Charles |
| The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer. The pharmacogenomics journal 2021 3 21 (4): 440-445. Shiota Masaki, Akamatsu Shusuke, Narita Shintaro, Sumiyoshi Takayuki, Fujiwara Maki, Uchiumi Takeshi, Ogawa Osamu, Habuchi Tomonori, Eto Masatos |
| Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer. Andrologia 2021 Nov e14307. Shiota Masaki, Fujimoto Naohiro, Sekino Yohei, Tsukahara Shigehiro, Nagakawa Shohei, Takamatsu Dai, Abe Tatsuro, Kinoshita Fumio, Ueda Shohei, Ushijima Miho, Matsumoto Takashi, Kashiwagi Eiji, Inokuchi Junichi, Uchiumi Takeshi, Oda Yoshinao, Eto Masatos |
| ASO Visual Abstract: Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen Receptor-Positive Breast Cancer. Annals of surgical oncology 2022 8 29 (11): 7204-7205. Flanagan Meghan R, Doody David R, Voutsinas Jenna, Wu Qian, Banda Kalyan, Sharifi Nima, Li Christopher I, Gadi Vijayakrishna |
| Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer. JNCI cancer spectrum 2022 8 6 (5): . McManus Jeffrey M, Vargas Roberto, Bazeley Peter S, Schumacher Fredrick R, Sharifi Ni |
| Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk. Molecular medicine reports 2022 Aug 26 (2): . Amrousy Yasmine M, Haffez Hesham, Abdou Doaa M, Atya Hanaa |
| Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer. Annals of surgical oncology 2022 Jul . Flanagan Meghan R, Doody David R, Voutsinas Jenna, Wu Qian, Banda Kalyan, Sharifi Nima, Li Christopher I, Gadi Vijayakrishna |
| A Phase II Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- and Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer. Journal of clinical pharmacology 2022 12 . Shiota Masaki, Inoue Ryo, Tashiro Kojiro, Kobayashi Keita, Horiyama Shizuyo, Kanji Hiromi, Eto Masatoshi, Egawa Shin, Haginaka Jun, Matsuyama Hideya |
| Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate. European journal of clinical pharmacology 2022 11 79 (1): 89-98. Takahashi Yoshiko, Narita Shintaro, Shiota Masaki, Miura Masatomo, Kagaya Hideaki, Kashima Soki, Yamamoto Ryohei, Nara Taketoshi, Huang Mingguo, Numakura Kazuyuki, Saito Mitsuru, Eto Masatoshi, Habuchi Tomono |
| The genomic landscape associated with resistance to aromatase inhibitors in breast cancer. Genomics & informatics 2023 7 21 (2): e20. Kirithika Sadasivam, Jeevitha Priya Manoharan, Hema Palanisamy, Subramanian Vidyalaksh |
| A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 11 169 115890. Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J H Coenen, Andries M Bergman, Stijn L W Koolen, Ronald de Wit, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijss |
| Connecting Gene Variation to Treatment Outcomes in Metastatic Castration-Resistant Prostate Adenocarcinoma: Insights into Second-Generation Androgen Receptor Axis-Targeted Therapies. International journal of molecular sciences 2024 9 25 (18): . Ana Vaz-Ferreira, Valéria Tavares, Inês Guerra de Melo, Patrícia Rafaela Rodrigues, Ana Afonso, Maria Joaquina Maurício, Rui Medeir |
| HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES. Cell reports. Medicine 2024 8 5 (8): 101644. Nima Sharifi, Arun A Azad, Mona Patel, Jason W D Hearn, Michele Wozniak, Fabian Zohren, Jennifer Sugg, Gabriel P Haas, Arnulf Stenzl, Andrew J Armstro |
| Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. The Prostate 2024 1 . Jason A White, Ernest T Kaninjing, Kayode A Adeniji, Paul Jibrin, John O Obafunwa, Chidiebere N Ogo, Faruk Mohammed, Ademola Popoola, Omolara A Fatiregun, Olabode P Oluwole, Roland J Thorpe, Balasubramanyam Karanam, Isra Elhussin, Stefan Ambs, Wei Tang, Melissa Davis, Paz Polak, Moray J Campbell, Kathryn R Brignole, Solomon O Rotimi, Windy Dean-Colomb, Folake T Odedina, Clayton Yat |
- Page last reviewed:Feb 1, 2024
- Content source: